









Markets
/
Stocks
/
nasdaq-ctnm
/

Contineum Therapeutics Inc

CTNM

12.200USD

-0.060-0.49%

Market hours （ET）Quotes delayed by 15 min

356.03MMarket Cap

LossP/E TTM



Contineum Therapeutics Inc

12.200

-0.060-0.49%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Contineum Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-97.71%-12.20M

-84.27%-15.66M

-80.71%-14.41M

4.69%-10.20M

-14.73%-6.17M

-120.90%-8.50M

-52.08%-7.97M

-162.55%-10.70M

---5.38M

--40.67M

---5.24M

---4.08M

Net income from continuing operations

-24.59%-12.79M

-78.04%-16.04M

-89.97%-15.99M

-87.48%-14.56M

-64.25%-10.27M

-121.68%-9.01M

-74.48%-8.42M

-3.42%-7.77M

---6.25M

--41.56M

---4.82M

---7.51M

Operating gains losses

30.65%81.00K

31.67%79.00K

27.87%78.00K

102.70%75.00K

44.19%62.00K

42.86%60.00K

-16.44%61.00K

-54.32%37.00K

--43.00K

--42.00K

--73.00K

--81.00K

Other non-cash items

142.93%237.00K

78.44%-180.00K

92.15%-52.00K

2.67%-913.00K

27.65%-552.00K

72.91%-835.00K

-22166.67%-662.00K

-138.29%-938.00K

---763.00K

---3.08M

--3.00K

--2.45M

Change in working capital

-198.88%-2.29M

-825.36%-1.93M

-493.45%-1.08M

205.73%2.95M

107.15%2.32M

-112.58%-209.00K

127.12%275.00K

-765.87%-2.79M

--1.12M

--1.66M

---1.01M

--419.00K

-Change in prepaid expenses

-367.82%-1.17M

-47.37%70.00K

-71.53%203.00K

-1541.67%-394.00K

135.11%435.00K

189.13%133.00K

1288.33%713.00K

-131.17%-24.00K

---1.24M

--46.00K

---60.00K

--77.00K

-Change in other current assets

-100.00%0.00

-100.64%-6.00K

----

-100.00%0.00

101.67%1.00K

3127.59%936.00K

-100.00%0.00

203.13%33.00K

---60.00K

--29.00K

--5.00K

---32.00K

-Change in other current liabilities

----

228.57%759.00K

---779.00K

----

--231.00K

Cash from non-recurring investing activities

Cash from operating activities

-97.71%-12.20M

-84.27%-15.66M

-80.71%-14.41M

4.69%-10.20M

-14.73%-6.17M

-120.90%-8.50M

-52.08%-7.97M

-162.55%-10.70M

---5.38M

--40.67M

---5.24M

---4.08M

Investing cash flow

Net cash from continuing investing activities

58.06%98.00K

-63.03%44.00K

-68.03%47.00K

-46.28%166.00K

181.82%62.00K

283.87%119.00K

182.69%147.00K

--309.00K

--22.00K

--31.00K

--52.00K

--0.00

Capital expenditures

19.51%98.00K

-63.03%44.00K

-68.03%47.00K

-46.28%166.00K

272.73%82.00K

283.87%119.00K

182.69%147.00K

--309.00K

--22.00K

--31.00K

--52.00K

--0.00

Net cash flow from disposal of fixed assets

58.06%98.00K

-63.03%44.00K

-68.03%47.00K

-46.28%166.00K

181.82%62.00K

283.87%119.00K

182.69%147.00K

--309.00K

--22.00K

--31.00K

--52.00K

--0.00

Net cash flow from investment products

149.93%15.04M

135.92%13.93M

68.53%14.96M

-198.75%-9.22M

23.69%-30.12M

12.71%-38.78M

-5.62%8.88M

89.93%9.34M

---39.47M

---44.43M

--9.41M

--4.92M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

149.50%14.94M

135.69%13.88M

70.83%14.91M

-203.96%-9.39M

23.58%-30.18M

12.50%-38.90M

-6.67%8.73M

83.65%9.03M

---39.50M

---44.46M

--9.36M

--4.92M

Financing cash flow

Cash flow from continuous financing activities

146861.54%19.11M

-99.92%91.00K

233.33%24.00K

300.00%642.00K

-99.87%13.00K

131.60%108.36M

97.08%-18.00K

48.64%-321.00K

--10.32M

--46.79M

---617.00K

---625.00K

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

----

---3.13M

---625.00K

Net cash flow from common stock issuance/repurchase

--19.01M

----

--0.00

--108.21M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

----

--0.00

--10.24M

--49.90M

----

--0.00

Proceeds from stock option exercised by employees

1230.77%173.00K

1953.85%267.00K

-80.33%24.00K

299.38%642.00K

--13.00K

-31.58%13.00K

1425.00%122.00K

-2246.67%-322.00K

----

--19.00K

--8.00K

--15.00K

Net cash flow from other financing activities

---80.00K

-225.71%-176.00K

100.00%0.00

----

--140.00K

---140.00K

106.67%1.00K

--82.00K

----

--0.00

---15.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

146861.54%19.11M

-99.92%91.00K

233.33%24.00K

300.00%642.00K

-99.87%13.00K

131.60%108.36M

97.08%-18.00K

48.64%-321.00K

--10.32M

--46.79M

---617.00K

---625.00K

Net cash flow

Beginning cash balance

-73.09%20.78M

38.16%22.47M

41.33%21.94M

133.38%40.89M

48.32%77.23M

79.45%16.26M

178.79%15.53M

227.25%17.52M

--52.07M

--9.06M

--5.57M

--5.35M

Current period cash flow changes

160.13%21.85M

-102.77%-1.69M

-28.59%527.00K

-849.77%-18.95M

-5.18%-36.34M

41.76%60.97M

-78.88%738.00K

-1027.91%-2.00M

---34.55M

--43.01M

--3.49M

--215.00K

Ending cash balance

4.26%42.63M

-73.09%20.78M

38.16%22.47M

41.33%21.94M

133.38%40.89M

48.32%77.23M

79.45%16.26M

178.79%15.53M

--17.52M

--52.07M

--9.06M

--5.57M

Free cash flow

-96.69%-12.29M

-82.23%-15.71M

-78.02%-14.46M

5.86%-10.37M

-15.78%-6.25M

-121.20%-8.62M

-53.36%-8.12M

-170.13%-11.01M

---5.40M

--40.64M

---5.30M

---4.08M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

